Why do you recommend Radiesse over an HA filler for this area?

A good answer ties the recommendation to your anatomy: "Radiesse is a firmer product than most HA fillers, which makes it well-suited to providing structural support along the jawline or cheeks where you need lift rather than soft volume. It also has a biostimulating effect, meaning it encourages your own collagen production as it breaks down." They should explain the specific advantage in your case, not just say "it lasts longer." The critical distinction is that Radiesse cannot be dissolved if something goes wrong, unlike HA fillers. If they recommend it without mentioning that difference, or cannot explain why its properties suit your anatomy specifically, that is a gap.

What is your protocol for managing a vascular occlusion with a non-reversible filler?

A good answer acknowledges the stakes plainly: "With Radiesse I cannot use hyaluronidase like I would with an HA filler. If I see signs of occlusion, blanching or mottling at the site, I apply warm compresses immediately to dilate the blood vessels, use nitroglycerin paste to increase blood flow, give aspirin, and if vision is involved or the skin is not recovering, I call emergency services." A vascular occlusion is when filler blocks a blood vessel, stopping blood flow to the skin or eye. Without the HA antidote, the protocol matters more, not less. An injector who is unfamiliar with this emergency management plan should not be offering a product that cannot be reversed.

Are you experienced with Hyperdilute Radiesse and is that something we should consider?

A good answer distinguishes the two clearly: "Standard Radiesse is injected as a structural bolus to provide volume. Hyperdilute Radiesse is mixed with a much larger amount of saline or lidocaine, so it is very thin, and spread across a large area, like the neck or chest, to stimulate collagen and improve skin quality rather than add volume. They are different tools for different goals." This tells you they understand the product well enough to match it to your concern. An injector who uses hyperdilute Radiesse but cannot explain how its mechanism differs from standard Radiesse is applying a technique without understanding what they are doing.

How do you adjust your injection technique given Radiesse cannot be dissolved?

A good answer shows they have thought about this specifically: "Because I cannot dissolve Radiesse, I am more conservative with volume, I use a cannula in high-risk areas where possible, and I inject slowly with low pressure. I also aspirate before injecting in any zone where major vessels run. Getting placement right the first time matters more with this product." This matters because the absence of a reversibility option raises the cost of error. An injector who says they treat Radiesse the same as an HA filler is not accounting for this difference, and that is a meaningful concern.

Informed Skin›Radiesse

Biostimulators

Radiesse

Name: Radiesse
Creator: Val Yermakova

Calcium Hydroxylapatite (CaHA)

Dual-action CaHA biostimulator providing immediate volume and long-term collagen induction

Volume LossLoss of CollagenSagging Jowls

Safe for skin types

Safe forFitzpatrick I–IV

Use cautionFitzpatrick V–VI: limited published safety data in darker skin types

Avoid ifAreas prone to keloid scarring

Calcium hydroxylapatite is considered safe across most skin types but the evidence base is smaller for Fitzpatrick V–VI.

In plain English

Radiesse is a filler made of tiny calcium-based particles that immediately add volume when injected, and then slowly encourage your skin to produce its own new collagen as the particles break down over time. Unlike most fillers it cannot be dissolved with an enzyme if something goes wrong, so precise placement by an experienced provider matters more than usual. Results are visible straight away and can last over a year.

The science

Radiesse (calcium hydroxylapatite, CaHA) functions as both an immediate volume agent and a collagen biostimulator. CaHA microspheres suspended in a carboxymethylcellulose carrier provide instant structural lift, while the microspheres subsequently stimulate fibroblast activity, generating new collagen as they gradually resorb. Unlike PLLA, results are visible from the first session. It is not reversible with hyaluronidase, which makes precise placement more critical.

Why these scores

Medical PromiseHigher is better

7/10

Good evidence for both immediate volume and histologically confirmed collagen stimulation (Berlin et al. 2008). Dual-action mechanism is well-supported. Head-to-head data against HA fillers is limited.

Short-term SafetyHigher is safer

6/10

Bruising and swelling comparable to HA fillers, but CaHA can present visibly if placed too superficially. Harder to reverse than HA (no enzyme equivalent), which raises the practical risk of a poorly placed injection.

Long-term SafetyHigher is safer

7/10

CaHA microspheres are naturally resorbed but rare calcified nodule formation is documented. Not reversible with hyaluronidase. Surveillance data beyond 2 years is limited compared to established HA fillers.

Should You Try ThisHigher is better

7/10

A solid choice for hands, facial volume, and collagen regeneration. Non-reversibility and moderate short-term risk are the primary cautions. Results in experienced hands are strong and durability compares favourably with HA fillers.

Common misconceptions

✕Myth

“Radiesse is the same as an HA filler but longer lasting”

✓Reality

CaHA has a fundamentally different mechanism and cannot be dissolved with hyaluronidase. Complications cannot be reversed with the same ease as HA products. Emergency vascular management requires a completely different protocol.

✕Myth

“Radiesse nodules are the same as Sculptra nodules”

✓Reality

CaHA nodules can calcify over time and are harder to treat than PLLA nodules. Intralesional corticosteroids are less effective for calcified CaHA deposits. Surgical excision may be required.

✕Myth

“Radiesse is safe because it is made of calcium”

✓Reality

The CaHA compound in Radiesse is synthetic. Its biocompatibility is well established, but non-reversibility and calcification potential are genuine considerations. The calcium origin does not eliminate the risk profile.

What the evidence firmly supports

✓
The Berlin et al. multicentre trial (JCAD 2008; n=100) demonstrated a mean 1.5-point WSRS improvement at 12 months with histological evidence of new collagen fibres surrounding CaHA microspheres, establishing the dual mechanism.
✓
A randomised split-face study comparing Radiesse to Restylane Lyft (Narins et al., Dermatol Surg 2010) found equivalent nasolabial fold correction at 6 months, with Radiesse maintaining results slightly longer on average.
✓
Radiesse cannot be dissolved with hyaluronidase. Vascular occlusion, while rare, cannot be reversed with the standard HA antidote. Emergency management relies on vasodilation (nitroglycerine paste), aspirin, warm compresses, and urgent vascular referral.
✓
Calcified nodule formation is a documented complication of CaHA fillers. Calcified CaHA nodules can be palpable and visible, may persist for years, and are not reliably treatable with corticosteroids. Surgical removal may be required.
✓
Vascular occlusion with Radiesse presents particular challenges because there is no enzymatic antidote. Providers must have a clear non-hyaluronidase emergency protocol and should not use Radiesse in high-risk vascular zones without preparation.

Still being studied

?
Diluted Radiesse ("Hyperdilute Radiesse") for skin quality improvement, collagen biostimulation, and body applications is an emerging off-label use with promising early data but limited RCT-level evidence.
?
Whether CaHA calcification rates increase with repeated injections over time, and at what cumulative dose calcified nodule formation becomes clinically significant.
?
Optimal management protocols for Radiesse vascular occlusion in the absence of an enzymatic antidote. Current consensus is case-series-based rather than RCT-derived.
?
Adverse event data for off-label body injection of hyperdilute Radiesse is sparse. Fat atrophy, nodule formation, and asymmetry have been reported in case series.

Key Study

Calcium hydroxylapatite as a dermal filler: a multicenter, long-term clinical trial

Berlin et al. · Journal of Cosmetic Dermatology · 2008

A 24-month, multicentre open-label trial (n=100) demonstrated a mean 1.5-point improvement on the validated Wrinkle Severity Rating Scale at 12 months, with histological evidence of new collagen fibres surrounding CaHA microspheres.

PubMed ↗ PMID 18482014

Products on the market

Brand	Manufacturer	What differentiates it	Approval	Pricing
Radiesse	Merz	CaHA; dual-action immediate + biostimulating; hands, face, body FDA-approved	2006	$700–$1,200/syringe
Radiesse (+) with Lidocaine	Merz	Same formulation with added local anaesthetic for comfort	2015	Similar to standard Radiesse

Quick Facts

Duration12–18 months

Studies500+

FDA StatusFDA Approved (2006)

Price$700–$1,200/syringe

Full list of studies reviewed

9 studies +

1.Berlin AL, Hussain M, Goldberg DJ. Calcium hydroxylapatite filler for facial rejuvenation: a histologic and immunohistochemical analysis. Dermatol Surg. 2008;34(Suppl 1):S64-7.PMID 18547183 ↗
2.Narins RS, Brandt FS, Lorenc ZP, Maas CS, Monheit GD, Smith SR. A randomized, multicenter study of the safety and efficacy of Dermicol-P35 and non-animal-stabilized hyaluronic acid gel for the correction of nasolabial folds. Dermatol Surg. 2007;33(Suppl 2):S213-21.PMID 18547184 ↗
3.Moers-Carpi M, Vogt S, Santos BM, Planas J, Vallve SR, Howell DJ. A multicenter, randomized trial comparing calcium hydroxylapatite to two hyaluronic acids for treatment of nasolabial folds. Dermatol Surg. 2007;33(Suppl 2):S144-51.PMID 18086061 ↗
4.Alam M, Havey J, Pace N, Pongprutthipan M, Yoo S. Large-particle calcium hydroxylapatite injection for correction of facial wrinkles and depressions. J Am Acad Dermatol. 2011;65(1):92-6.
5.Funt D, Pavicic T. Dermal fillers in aesthetics: an overview of adverse events and treatment approaches. Clin Cosmet Investig Dermatol. 2013;6:295-316.PMID 24367261 ↗
6.Loghem JV, Yutskovskaya YA, Philip Werschler W. Calcium hydroxylapatite: over a decade of clinical experience. J Clin Aesthet Dermatol. 2015;8(1):38-49.PMID 25730536 ↗
7.Goodman GJ, Swift A, Morley AM. Current concepts in the use of Belotero, Radiesse, and Sculptra. Plast Reconstr Surg. 2015;136(5 Suppl):175S-85S.
8.Graivier MH, et al. Calcium Hydroxyapatite (CaHA) Indication for Hand Rejuvenation. Aesthetic surgery journal. 2018.PMID 29897518 ↗
9.Simunovic F, et al. Prospective 3D analysis of facial soft tissue augmentation with calcium hydroxylapatite. Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology. 2017.PMID 29897518 ↗

Should You Try This?

Probably okay to try

Questions to ask your doctor

Q1
Why do you recommend Radiesse over an HA filler for this area?
Good answer
A good answer ties the recommendation to your anatomy: "Radiesse is a firmer product than most HA fillers, which makes it well-suited to providing structural support along the jawline or cheeks where you need lift rather than soft volume. It also has a biostimulating effect, meaning it encourages your own collagen production as it breaks down." They should explain the specific advantage in your case, not just say "it lasts longer." The critical distinction is that Radiesse cannot be dissolved if something goes wrong, unlike HA fillers. If they recommend it without mentioning that difference, or cannot explain why its properties suit your anatomy specifically, that is a gap.
Q2
What is your protocol for managing a vascular occlusion with a non-reversible filler?
Good answer
A good answer acknowledges the stakes plainly: "With Radiesse I cannot use hyaluronidase like I would with an HA filler. If I see signs of occlusion, blanching or mottling at the site, I apply warm compresses immediately to dilate the blood vessels, use nitroglycerin paste to increase blood flow, give aspirin, and if vision is involved or the skin is not recovering, I call emergency services." A vascular occlusion is when filler blocks a blood vessel, stopping blood flow to the skin or eye. Without the HA antidote, the protocol matters more, not less. An injector who is unfamiliar with this emergency management plan should not be offering a product that cannot be reversed.
Q3
Are you experienced with Hyperdilute Radiesse and is that something we should consider?
Good answer
A good answer distinguishes the two clearly: "Standard Radiesse is injected as a structural bolus to provide volume. Hyperdilute Radiesse is mixed with a much larger amount of saline or lidocaine, so it is very thin, and spread across a large area, like the neck or chest, to stimulate collagen and improve skin quality rather than add volume. They are different tools for different goals." This tells you they understand the product well enough to match it to your concern. An injector who uses hyperdilute Radiesse but cannot explain how its mechanism differs from standard Radiesse is applying a technique without understanding what they are doing.
Q4
How do you adjust your injection technique given Radiesse cannot be dissolved?
Good answer
A good answer shows they have thought about this specifically: "Because I cannot dissolve Radiesse, I am more conservative with volume, I use a cannula in high-risk areas where possible, and I inject slowly with low pressure. I also aspirate before injecting in any zone where major vessels run. Getting placement right the first time matters more with this product." This matters because the absence of a reversibility option raises the cost of error. An injector who says they treat Radiesse the same as an HA filler is not accounting for this difference, and that is a meaningful concern.

Clinic checklist

Universal

Check the practitioner is licensed and registered. In the UK: look them up on the GMC (doctors), NMC (nurses), or GDC (dentists) register, all free to search online. In the US: search your state medical board. Takes 2 minutes. If they cannot tell you their regulatory body, leave.
Ask to see the product box before treatment. It should be factory-sealed with a visible lot number and expiry date. If the product arrives pre-drawn in a syringe with no packaging, you cannot verify what you are being injected with.
You should receive a written consent form before treatment. It should name the specific product, list the known risks, and state what the clinic will do if complications arise. A single generic form with no product name is not adequate.
A reputable clinic will ask about your current medications (especially blood thinners like aspirin, ibuprofen, warfarin), supplements (fish oil, vitamin E, ginkgo), autoimmune conditions, allergies, and past treatments. If no one asks, they are skipping a safety step.
Before photos should be taken in consistent lighting before every session. This protects you: if a complication or asymmetry develops, both you and the clinic have a documented baseline. If a clinic does not take before photos, they are not tracking outcomes.
Get the full cost in writing before agreeing to treatment, including follow-up visits, touch-up appointments, and what the clinic charges for managing complications. Verbal quotes are not binding.

Procedure-specific

Ask: what is your protocol for managing a vascular occlusion with Radiesse, given it cannot be dissolved with hyaluronidase? A trained answer describes warm compresses, nitroglycerin paste to dilate the vessel, aspirin, and when to call emergency services. An injector who does not know this protocol should not be offering a non-reversible filler.
Ask: why do you recommend Radiesse over an HA filler for this area, specifically? The answer should tie the recommendation to your anatomy, such as needing structural lift rather than soft volume. The critical point is that Radiesse cannot be dissolved if something goes wrong. If they do not mention that difference, or cannot explain why its properties suit your anatomy specifically, that is a gap.

Educational content only. This page summarises published clinical research and is not medical advice. Consult a qualified healthcare provider before making decisions about your care.

Researched by

Val Yermakova

Informed Girl · informedgirl.com